chrisvoncsefalvay/vaers-outcomes huggingface dataset:
nurse administered into her shoulder joint instead of deltoid muscle; arm  and fingers started tingling; redness at injection site; ridiculous pain; sore; puffy  at the injection site; arm was sore; arm was puffy; patient could not move her arm away from her body; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (nurse administered into her shoulder joint instead of deltoid muscle), PARAESTHESIA (arm  and fingers started tingling), INJECTION SITE ERYTHEMA (redness at injection site), PAIN (ridiculous pain) and ARTHRALGIA (sore) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (nurse administered into her shoulder joint instead of deltoid muscle), PARAESTHESIA (arm  and fingers started tingling), INJECTION SITE ERYTHEMA (redness at injection site), PAIN (ridiculous pain), ARTHRALGIA (sore), INJECTION SITE SWELLING (puffy  at the injection site), PAIN IN EXTREMITY (arm was sore), PERIPHERAL SWELLING (arm was puffy) and MOBILITY DECREASED (patient could not move her arm away from her body). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 29-Apr-2021, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (nurse administered into her shoulder joint instead of deltoid muscle) had resolved. At the time of the report, PARAESTHESIA (arm  and fingers started tingling), INJECTION SITE ERYTHEMA (redness at injection site), PAIN (ridiculous pain), ARTHRALGIA (sore), INJECTION SITE SWELLING (puffy  at the injection site), PAIN IN EXTREMITY (arm was sore), PERIPHERAL SWELLING (arm was puffy) and MOBILITY DECREASED (patient could not move her arm away from her body) outcome was unknown.             Action taken on mRNA-1273 in response to the events was not applicable.
Woke up the next morning with uncontrollable nausea and vomiting. This lasted for 24 straight until I went to the hospital and received an intermuscular shot and a prescription for nausea medication. Also had sensitivity to light.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Jul2022 at 10:00 as dose 4 (booster), single (Lot number: FP7138) at the age of 67 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "neuropathy" (unspecified if ongoing); "Sensitive to nightshades" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Valium, reaction(s): "Allergic to Valium", notes: Allergic to Valium. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.
breastfeeding patient received first dose; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (breastfeeding patient received first dose) in a 29-year-old female adult exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M2DA) , while the mother received the product for COVID-19 vaccination.    MEDICAL HISTORY (Parent): The mother's past medical history included Maternal exposure during breast feeding.    MEDICAL HISTORY (Patient): Concomitant product exposures included LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS.    On 10-Mar-2021, the mother received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 10-Mar-2021, the adult was diagnosed with EXPOSURE VIA BREAST MILK (breastfeeding patient received first dose). At the time of the report, EXPOSURE VIA BREAST MILK (breastfeeding patient received first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Upon internal review on 19-May-21, the age was corrected 29 years.
After receiving my second dose, I experienced sore throat, cough, itchy/watery eyes, fever and sinus pressure. I became a little short of breath and had chest tightness. I experienced squeezing around my heart, occasionally, since my first dose. I have also experienced dizziness, wheezing, feeling groggy, a bit of confusion and have had a lot of drainage.
Fever, headache, dizziness, and diffuse joint pains x 1 day, responsive to Motrin.
pt recv vax 2PM started itching around 245PM according to student; pt did not tell anyone until 315Pm when c/o tongue feeling funny, hives on face & neck, lt palm itching; given DPH
Throat Swollen; Rash; This is a spontaneous report from a contactable consumer or other non-health care professional reported for patient.   A 61-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0179, Expiry date: not reported), via an unspecified route of administration, administered in Arm Left on 06Aug2021 (age at vaccination was unknown) at 10:00 as dose 1, single for COVID19 immunization. The patient medical history was not reported. Concomitant medication included diphenhydramine hydrochloride, paracetamol (TYLENOL PM); caffeine, magnesium salicylate (DIUREX WATER PILLS). On 08Aug2021, the patient experienced throat swollen, rash. No investigation assessment. Patient got the Pfizer Covid 19 Vaccine first dose on Friday and reports that she can breathe but has a swollen throat and rash. It did not happen immediately after the dose; it was 2 days later that patient had the Side effect. The consumer called to ask when the rash is going to go away. Caller confirmed information provided by the transferring agent. Caller at first provides 60 but then states wait she doesn't know her age and then confirms as 61. The patient has not seen the doctor in a long time. It initially started in the stomach area, then later at night after patient slept and woke up, consumer noticed they had the rash on the inside of both her arms, but it is not as bad as the stomach. The rash looks like little red dots. Patient only took Tylenol PM on the day of the first dose because her arm was hurting. Consumer took a water pill called Diurex that is over the counter. The outcome of the events was not resolved.  Follow-up attempts are completed. No further information is expected.
Information has been received from a medical assistant on 02-JUL-2015 concerning a patient of unknown age and gender. On 28-APR-2015, the patient was vaccinated with a dose of LIQUID PEDVAXHIB (lot # K008878) 0.5 ml (expiration date, route and site of administration  were not reported) that underwent 46 hours temperature excursion. No adverse effects had been observed or reported. This is one several reports from the same reporter. Additional information has been requested.
24 hours after vaccination patient experienced fever, body aches, nausea, and ear pain. 1 episode of vomiting 24 hours later. Also presented with headache. Symptoms improved 24 hours later but still had general feeling of unwellness. Took MOTRIN x 1 dose. Patient was observed and monitored, stable. Advised RTO if no further improvement or worsening of symptoms.
31 year old female found supine of ground, in care of clinic staff, and unconscious.  Clinic staff states patient had a witnessed syncopal episode 2-3 minutes after administration of her second dose of the COVID-19 vaccine.  Patient quickly regained consciousness and reports similar episodes to "needles" in the past.   Patient denied other complaints including head / neck / back / chest / abdominal / extremity pain, difficulty breathing, dizziness / nausea / vomiting, recent illness or injury. Patient consented to assessment, but refused transport to emergency department for further evaluation.  She was advised not to drive herself home, and had a friend who also had an appointment today drive her home instead.  Patient also advised to follow up with emergency department and/or call 911 as appropriate.  Patient expressed understanding and agreed to comply.
quadracel vaccine was accidentally mixed with a sterile diluent and administered to a patient with no reported adverse event; Initial information received on 26-May-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a patient with unknown demographics and diphtheria-15/tetanus/5 hybrid AC pertussis/IPV (MRC5) vaccine [Quadracel] was accidentally mixed with a sterile diluent and administered to a patient with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Diphtheria-15/Tetanus/5 Hybrid AC Pertussis/IPV (MRC5) Vaccine Suspension for injection strength, dose, expiry date, lot number not reported via unknown route in unknown administration site for prophylactic vaccination(immunization).Information on the batch number was requested.  On an unknown date the patient developed a non-serious quadracel vaccine was accidentally mixed with a sterile diluent and administered to a patient with no reported adverse event (product preparation error) (unknown latency) following the administration of vaccine.  It was reported "She wants to find out if the vaccine would need to be readministered".  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event quadracel vaccine was accidentally mixed with a sterile diluent and administered to a patient with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Uncontrollable Shaking High Fever (Above 101) Chills Upset Stomach  Vomiting Body Aches Bumps on legs Trouble Breathing
pt recvd vax;4-4 1/2 p/ vax,swelling at inject site; fever 99.5;swelling dec w/in 18 hrs; cranky but sleeped well;no problems by next day;
About 1 hour after the first vaccine shot, I started to have typical symptoms -- achy body, tightness of breath, basic flu like symptoms. About 3 hours after the vaccine I started having sharp pain (like 8 or 9 on a scale of 1-10) running down the insides of my legs. It felt like lightning was running through my body. I tried to sleep Friday as well as the weekend, and the pain was intense. I had to limit and stop all exercise, and to-date, I can only walk for limited times before I feel pain in my legs again. I have also long-term lethargy and tireness, and find I am sleeping 12-16 hours a day. Prior to Covid vaccine, I would only sleep 4-6 hours a night.
This spontaneous report was received from a respiratory therapist refers to a one among 23 unspecified patients, age and gender were unknown. Medical history was not reported. The respiratory therapist informed that between 01-FEB-2014 through 31-MAY-2014 the patient was vaccinated with PNEUMOVAX 23, lot number, H003390 expiration date 16-JUL-2014 (route, strength and dosage were not reported), which was improperly stored. Concomitant therapy was not reported. No adverse effects were reported. No product quality complaint (PQC) filed. The action taken was assessed as not applicable. The causality was assessed as not related to the suspect therapy. This is one of several reports received from the same reporter. Follow up information has been received. Lot number H002280 is an invalid lot numbers for PNEUMOVAX 23. Additional information has been requested.
Closed displaced spiral fracture of shaft of right femur. Procedure - Right - TROCHANTERIC FIXATION NAILING right hip. The hospitalization was necessary for pain control, therapy, medical care and discharge placement. Ultimately, the patient was discharged to skilled nursing facility under satisfactory medical and post-operative condition. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
About one week after receiving my first dose of Moderna, my arm became very itchy at the injection site for about a day. One week from that day (so 14 days after my vaccine) I noticed I had a hard, swollen, bump like circle/rash -like ring around the injection site.  It lasted less than 24 hours and then was completely gone.
I started feeling a stabbing pain in the Lymph Nodes under my left arm. It got worse and you could feel the nodes under my arm. A 2in diameter bruise where I got my shot. The bruise lasted 2 weeks and temperature of left arm was warm to touch. Lymph nodes were swollen for at least 5 days.  No symptoms after the second dose
HIVES/ITCHING; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced hives/itching. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from hives/itching. This report was non-serious. This case, involving the same patient is linked to 20210762228.
Presented to the ED with shortness of breath, cough, fever, myalgias, and fatigue. Tested positive for COVID 5 days ago, 70% O2 sat Was given oxygen, decadron prednisolone, zinc, vitamin D, melatonin, remdesivir, budesonide Became unresponsive and died
About three months after receiving the vaccine, I suddenly lost hearing in my right ear. My doctor diagnosed me with Sudden Sensorineural Hearing Loss and prescribed Prednisone to treat it. I'm not sure if this is related to the vaccine, but I've read reports of people who recovered from covid or received the vaccine experiencing hearing loss, so I thought I would submit it here just in case it's related. (I have never tested positive for covid, nor did I ever suspect that I had it)
I experienced extreme soreness at the injection site, fatigue, fever, chills, muscle and joint aches for two straight days following the injection. I had to stay in bed for two full days.
Throat started swelling and could not hardly talk; Throat started swelling and could not hardly talk; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 58-year-old non pregnant female patient received second dose of bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: ER8730) via an unspecified route of administration, administered in right arm on 29Mar2021 (at the age of 58-year-old) at single dose for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. The patient's medical history included chronic obstructive pulmonary disease from an unknown date and unknown if ongoing and Penicillin allergy. The patient's concomitant medications were not reported. The patient's historical vaccine included first dose of bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN6199) via an unspecified route of administration, administered in left arm on 01Mar2021 at 08:15 AM (at the age of 58-year-old) at single dose for COVID-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was reported as other and the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19 and since the vaccination, patient had not been tested for COVID-19. Vaccine Facility information was available at the time of report. On 29Mar2021 at 08:45, the patient experienced throat started swelling and could not hardly talk. The patient did not receive any treatment for the events. The adverse event did not result in anything. The clinical outcome of events was reported as recovered with sequelae (lasting effects).  No follow-up attempts are needed. No further information is expected.
Once he awoke in the morning, he had a high fever of 102 F, in additional the injection site was hot, red & swollen.  The symptoms lasted 2 days so far.
This spontaneous report was received from a Registered Nurse and refers to 11 unspecified patients of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On unspecified dates, 11 patients were vaccinated with improperly stored doses of GARDASIL (lot # J009788, expiration date 17-MAR-2016; lot# K007264, expiration date unknown) (dose, indication and route of administration were not reported). Concomitant therapy was not provided. No adverse effect was reported. Additional information has been requested.
Patient received expired dose of Moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of Moderna vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of Moderna vaccine). On 17-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported. No treatment information was provided.
Joint pain; Tired; Chills; Severe arm pain; Achy; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint pain), FATIGUE (Tired), CHILLS (Chills), PAIN IN EXTREMITY (Severe arm pain) and MYALGIA (Achy) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced ARTHRALGIA (Joint pain), FATIGUE (Tired), CHILLS (Chills), PAIN IN EXTREMITY (Severe arm pain) and MYALGIA (Achy). On 09-Mar-2021, ARTHRALGIA (Joint pain), FATIGUE (Tired), CHILLS (Chills), PAIN IN EXTREMITY (Severe arm pain) and MYALGIA (Achy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication provided.  No treatment drugs were provided.   This case was linked to MOD-2021-071681 (E2B Linked Report).; Sender's Comments:  MOD-2021-071681:2nd dose
This spontaneous report was received from a certified medical assistant and refers to multiple patients of unknown age and gender. No information regarding the patients' medical history, concurrent conditions and concomitant medications was provided. On unknown dates, the patients received doses of improperly stored PNEUMOVAX 23 lot# L035882 with expiration date: 19-APR-2017 (dose and route of administration were not reported). Administered doses of PNEUMOVAX 23 underwent temperature excursions at 31 Fahrenheit degrees, for 189 hours (7 days and 21 hours) (2 cycles). Information about the previous temperature excursions was not reported. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Extremely  itchy nummular rash on hands and feet; few other spots on left elbow and right thigh. Treatment with OTC anti-histamines and prescription steroid cream started 1/15/21;  extreme itching started to dissipate 1/16/21; rash still evident 1/17/21
pt recv vax & devel an inj site rxn characterized by redness & swelling w/pain radiating from site down the arm;pt had recv vax in  the past;this is one of ten patients who exp above rxn p/vax;
Information has been received from a physician concerning a 13 year old female who on 29-OCT-2007 was vaccinated with Gardasil intramuscularly. On 29-OCT-2007 after standing up from the examination table, the patient felt light headed. The patient was placed on a chair and fainted shortly thereafter. Seizure activity started after the patient had been unconsciousness approximately 10 seconds and lasted approximately 5-10 seconds. The patient regained unconsciousness. Vital signs were taken which were normal. The patient was observed for 20 minutes. An EEG was ordered (results not reported) and the patient was release with her mom. On 29-OCT-2007 the patient recovered from the seizure and fainting. Upon internal review seizure was determined to be an other important medical event. Additional information is expected.
Rash well below vaccine site on right upper arm... shape was irregular but symmetrical, wide but not tall. It looked almost like an arm band, except that it was only on the outside part of the arm.
While in hospital to deliver baby, patient was routinely tested for covid and tested positive. She is asymptomatic. Baby was delivered by C section for breech presentation. Mom and baby doing well.
The patient came in to the emergency department for a visit. he stated while in the ed that he had an appointment that was scheduled for today that he was going to miss. Glancing at the system the nurse and myself thought it actually did state 07/06/2021. I administered the vaccine and went on to chart the dose given. Upon going in to remove the patient's appointment I realized we misread the date and the patient was actually scheduled for 7/16/21. So the patient was actually 6 days earlier for his 2nd dose than what was recommended
Developed three nonocclusive clots in my left leg.  No history of trauma, surgery, or other contributing factors.  I am currently being treated with blood thinners.